{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T17:24:02Z","timestamp":1779384242227,"version":"3.53.1"},"reference-count":155,"publisher":"Elsevier BV","issue":"21","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T00:00:00Z","timestamp":1754352000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100015691","name":"National Institute of Allergy and Infectious Diseases Division of Microbiology and Infectious Diseases","doi-asserted-by":"publisher","award":["F30AI181462"],"award-info":[{"award-number":["F30AI181462"]}],"id":[{"id":"10.13039\/100015691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015691","name":"National Institute of Allergy and Infectious Diseases Division of Microbiology and Infectious Diseases","doi-asserted-by":"publisher","award":["P01AI120943"],"award-info":[{"award-number":["P01AI120943"]}],"id":[{"id":"10.13039\/100015691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007921","name":"University of Pittsburgh","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007921","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular Biology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.jmb.2025.169366","type":"journal-article","created":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T15:03:31Z","timestamp":1753974211000},"page":"169366","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["25\u00a0Years of Ebola Virus VP35 Research"],"prefix":"10.1016","volume":"437","author":[{"given":"Grace","family":"Uwase","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisy W.","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0418-9707","authenticated-orcid":false,"given":"Gaya K.","family":"Amarasinghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmb.2025.169366_b0005","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/s00705-023-05834-2","article-title":"Renaming of genera Ebolavirus and Marburgvirus to Orthoebolavirus and Orthomarburgvirus, respectively, and introduction of binomial species names within family Filoviridae","volume":"168","author":"Biedenkopf","year":"2023","journal-title":"Arch. Virol."},{"key":"10.1016\/j.jmb.2025.169366_b0010","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0140-6736(10)60667-8","article-title":"Ebola haemorrhagic fever","volume":"377","author":"Feldmann","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.jmb.2025.169366_b0015","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1146\/annurev-pathol-052016-100506","article-title":"The pathogenesis of Ebola virus disease","volume":"12","author":"Baseler","year":"2017","journal-title":"Annu. Rev. Pathol. Mech. Dis."},{"key":"10.1016\/j.jmb.2025.169366_b0020","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41572-020-0147-3","article-title":"Ebola virus disease","volume":"6","author":"Jacob","year":"2020","journal-title":"Nature Rev. Dis. Primers"},{"key":"10.1016\/j.jmb.2025.169366_b0025","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1006\/viro.2001.0836","article-title":"Monocyte-derived human macrophages and peripheral blood mononuclear cells infected with Ebola virus secrete MIP-1alpha and TNF-alpha and inhibit poly-IC-induced IFN-alpha in vitro","volume":"284","author":"Gupta","year":"2001","journal-title":"Virology"},{"key":"10.1016\/j.jmb.2025.169366_b0030","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0042-6822(03)00233-2","article-title":"Protection from lethal infection is determined by innate immune responses in a mouse model of Ebola virus infection","volume":"312","author":"Mahanty","year":"2003","journal-title":"Virology"},{"key":"10.1016\/j.jmb.2025.169366_b0035","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.1128\/JVI.73.4.3491-3496.1999","article-title":"Ebola virus selectively inhibits responses to interferons, but not to interleukin-1beta, in endothelial cells","volume":"73","author":"Harcourt","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.jmb.2025.169366_b0040","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.bbrc.2019.10.147","article-title":"Ebola virus replication is regulated by the phosphorylation of viral protein VP35","volume":"521","author":"Zhu","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jmb.2025.169366_b0045","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1016\/j.biocel.2005.02.018","article-title":"Ebola virus: the role of macrophages and dendritic cells in the pathogenesis of Ebola hemorrhagic fever","volume":"37","author":"Bray","year":"2005","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.jmb.2025.169366_b0050","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1016\/S0002-9440(10)63591-2","article-title":"Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques","volume":"163","author":"Geisbert","year":"2003","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jmb.2025.169366_b0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1462399404008300","article-title":"Ebola virus: new insights into disease aetiopathology and possible therapeutic interventions","volume":"6","author":"Geisbert","year":"2004","journal-title":"Expert Rev. Mol. Med."},{"key":"10.1016\/j.jmb.2025.169366_b0060","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/nrmicro3524","article-title":"Filovirus pathogenesis and immune evasion: insights from Ebola virus and Marburg virus","volume":"13","author":"Messaoudi","year":"2015","journal-title":"Nature Rev. Microbiol."},{"key":"10.1016\/j.jmb.2025.169366_b0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0000837","article-title":"Human fatal Zaire Ebola virus infection is associated with an aberrant innate immunity and with massive lymphocyte apoptosis","volume":"4","author":"Wauquier","year":"2010","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.jmb.2025.169366_b0070","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1046\/j.1365-2249.2002.01800.x","article-title":"Inflammatory responses in Ebola virus-infected patients","volume":"128","author":"Baize","year":"2002","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jmb.2025.169366_b0075","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0165-2478(01)00327-3","article-title":"Proinflammatory response during Ebola virus infection of primate models: possible involvement of the tumor necrosis factor receptor superfamily","volume":"80","author":"Hensley","year":"2002","journal-title":"Immunol. Letters"},{"key":"10.1016\/j.jmb.2025.169366_b0080","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0042-6822(85)90236-3","article-title":"Descriptive analysis of Ebola virus proteins","volume":"147","author":"Elliott","year":"1985","journal-title":"Virology"},{"key":"10.1016\/j.jmb.2025.169366_b0085","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/BF01313780","article-title":"Ebola protein analyses for the determination of genetic organization","volume":"133","author":"Elliott","year":"1993","journal-title":"Arch. Virol."},{"key":"10.1016\/j.jmb.2025.169366_b0090","series-title":"Unconventional Agents and Unclassified Viruses","first-page":"81","article-title":"Molecular biology and evolution of filoviruses","author":"Feldmann","year":"1993"},{"key":"10.1016\/j.jmb.2025.169366_b0095","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0168-1702(93)90063-S","article-title":"Sequence analysis of the Ebola virus genome: organization, genetic elements, and comparison with the genome of Marburg virus","volume":"29","author":"Sanchez","year":"1993","journal-title":"Virus Res."},{"key":"10.1016\/j.jmb.2025.169366_b0100","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1038\/s41564-024-01703-z","article-title":"Molecular insights into the Ebola virus life cycle","volume":"9","author":"Bodmer","year":"2024","journal-title":"Nature Microbiol."},{"key":"10.1016\/j.jmb.2025.169366_b0105","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/s41579-019-0233-2","article-title":"Therapeutic strategies to target the Ebola virus life cycle","volume":"17","author":"Hoenen","year":"2019","journal-title":"Nature Rev. Microbiol."},{"key":"10.1016\/j.jmb.2025.169366_b0110","doi-asserted-by":"crossref","first-page":"55750","DOI":"10.18632\/oncotarget.18498","article-title":"The lifecycle of the Ebola virus in host cells","volume":"8","author":"Yu","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jmb.2025.169366_b0115","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/nature10348","article-title":"Ebola virus entry requires the cholesterol transporter Niemann-Pick C1","volume":"477","author":"Carette","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.jmb.2025.169366_b0120","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/nature10380","article-title":"Small molecule inhibitors reveal Niemann-Pick C1 is essential for Ebola virus infection","volume":"477","author":"C\u00f4t\u00e9","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.jmb.2025.169366_b0125","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0014-5793(93)81107-B","article-title":"The VP35 and VP40 proteins of filoviruses. Homology between Marburg and Ebola viruses","volume":"322","author":"Bukreyev","year":"1993","journal-title":"FEBS Letters"},{"key":"10.1016\/j.jmb.2025.169366_b0130","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1128\/JVI.73.3.2333-2342.1999","article-title":"Comparison of the transcription and replication strategies of Marburg Virus and Ebola Virus by using artificial replication systems","volume":"73","author":"M\u00fchlberger","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.jmb.2025.169366_b0135","doi-asserted-by":"crossref","first-page":"12289","DOI":"10.1073\/pnas.220398297","article-title":"The Ebola virus VP35 protein functions as a type I IFN antagonist","volume":"97","author":"Basler","year":"2000","journal-title":"PNAS"},{"key":"10.1016\/j.jmb.2025.169366_b0140","doi-asserted-by":"crossref","first-page":"7945","DOI":"10.1128\/JVI.77.14.7945-7956.2003","article-title":"The Ebola virus VP35 protein inhibits activation of interferon regulatory factor 3","volume":"77","author":"Basler","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.jmb.2025.169366_b0145","doi-asserted-by":"crossref","first-page":"5168","DOI":"10.1128\/JVI.02199-05","article-title":"Ebola virus VP35 protein binds double-stranded RNA and inhibits alpha\/beta interferon production induced by RIG-I signaling","volume":"80","author":"C\u00e1rdenas","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.jmb.2025.169366_b0150","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.virol.2004.07.006","article-title":"A C-terminal basic amino acid motif of Zaire ebolavirus VP35 is essential for type I interferon antagonism and displays high identity with the RNA-binding domain of another interferon antagonist, the NS1 protein of influenza A virus","volume":"328","author":"Hartman","year":"2004","journal-title":"Virology"},{"key":"10.1016\/j.jmb.2025.169366_b0155","doi-asserted-by":"crossref","first-page":"8756","DOI":"10.1128\/JVI.72.11.8756-8764.1998","article-title":"Three of the four nucleocapsid proteins of Marburg virus, NP, VP35, and L, are sufficient to mediate replication and transcription of Marburg virus-specific monocistronic minigenomes","volume":"72","author":"M\u00fchlberger","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.jmb.2025.169366_b0160","doi-asserted-by":"crossref","first-page":"14628","DOI":"10.1073\/pnas.1209147109","article-title":"Critical phosphoprotein elements that regulate polymerase architecture and function in vesicular stomatitis virus","volume":"109","author":"Rahmeh","year":"2012","journal-title":"PNAS"},{"key":"10.1016\/j.jmb.2025.169366_b0165","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/bs.enz.2021.09.002","article-title":"Structure and function of negative-strand RNA virus polymerase complexes","volume":"50","author":"Pyle","year":"2021","journal-title":"Enzymes"},{"key":"10.1016\/j.jmb.2025.169366_b0170","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1146\/annurev-virology-111821-102603","article-title":"Structures and mechanisms of nonsegmented, negative-strand RNA virus polymerases","volume":"10","author":"Ouizougun-Oubari","year":"2023","journal-title":"Annu. Rev. Virol."},{"key":"10.1016\/j.jmb.2025.169366_b0175","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.3389\/fmicb.2019.01490","article-title":"RNA synthesis and capping by non-segmented negative strand RNA viral polymerases: lessons from a prototypic virus","volume":"10","author":"Ogino","year":"2019","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.jmb.2025.169366_b0180","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.celrep.2015.03.034","article-title":"An intrinsically disordered peptide from Ebola virus VP35 controls viral RNA synthesis by modulating nucleoprotein-RNA interactions","volume":"11","author":"Leung Daisy","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.jmb.2025.169366_b0185","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.celrep.2015.06.003","article-title":"Assembly of the Ebola virus nucleoprotein from a chaperoned VP35 complex","volume":"12","author":"Kirchdoerfer Robert","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.jmb.2025.169366_b0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2023.168241","article-title":"Disruption of Ebola NP0VP35 inclusion body-like structures reduce viral infection","volume":"435","author":"Wu","year":"2023","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jmb.2025.169366_b0195","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1021\/acsinfecdis.6b00209","article-title":"A sensitive in vitro high-throughput screen to identify pan-filoviral replication inhibitors targeting the VP35-NP interface","volume":"3","author":"Liu","year":"2017","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.jmb.2025.169366_b0200","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/s41586-023-06608-1","article-title":"Molecular mechanism of de novo replication by the Ebola virus polymerase","volume":"622","author":"Peng","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.jmb.2025.169366_b0205","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/s41586-022-05271-2","article-title":"Structure of the Ebola virus polymerase complex","volume":"610","author":"Yuan","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.jmb.2025.169366_b0210","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.str.2018.09.009","article-title":"Structures of Ebola and Reston virus VP35 oligomerization domains and comparative biophysical characterization in all Ebolavirus species","volume":"27","author":"Zinzula","year":"2019","journal-title":"Structure"},{"key":"10.1016\/j.jmb.2025.169366_b0215","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1021\/acs.biochem.8b01154","article-title":"The Ebola viral protein 35 N-terminus is a parallel tetramer","volume":"58","author":"Chanthamontri","year":"2019","journal-title":"Biochemistry"},{"key":"10.1016\/j.jmb.2025.169366_b0220","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.virol.2005.06.044","article-title":"Homo-oligomerization facilitates the interferon-antagonist activity of the ebolavirus VP35 protein","volume":"341","author":"Reid","year":"2005","journal-title":"Virology"},{"key":"10.1016\/j.jmb.2025.169366_b0225","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1073\/pnas.0910547107","article-title":"VP35 uses a bimodal strategy to bind dsRNA for innate immune suppression","volume":"107","author":"Kimberlin","year":"2010","journal-title":"PNAS"},{"key":"10.1016\/j.jmb.2025.169366_b0230","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.virusres.2018.02.003","article-title":"Insights into the homo-oligomerization properties of N-terminal coiled-coil domain of Ebola virus VP35 protein","volume":"247","author":"Ramaswamy","year":"2018","journal-title":"Virus Res."},{"key":"10.1016\/j.jmb.2025.169366_b0235","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.pep.2009.02.008","article-title":"Purification and functional characterization of the full length recombinant Ebola virus VP35 protein expressed in E. coli","volume":"66","author":"Zinzula","year":"2009","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.jmb.2025.169366_b0240","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/nsmb.1765","article-title":"Structural basis for dsRNA recognition and interferon antagonism by Ebola VP35","volume":"17","author":"Leung","year":"2010","journal-title":"Nature Struct. Mol. Biol."},{"key":"10.1016\/j.jmb.2025.169366_b0245","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1073\/pnas.0807854106","article-title":"Structure of the Ebola VP35 interferon inhibitory domain","volume":"106","author":"Leung","year":"2009","journal-title":"PNAS"},{"key":"10.1016\/j.jmb.2025.169366_b0250","doi-asserted-by":"crossref","first-page":"526","DOI":"10.4161\/viru.1.6.12984","article-title":"VP35 is a multifunctional virulence factor","volume":"1","author":"Leung","year":"2010","journal-title":"Virulence"},{"key":"10.1016\/j.jmb.2025.169366_b0255","doi-asserted-by":"crossref","first-page":"10581","DOI":"10.1128\/JVI.00925-10","article-title":"Basic residues within the Ebolavirus VP35 protein are required for its viral polymerase cofactor function","volume":"84","author":"Prins","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.jmb.2025.169366_b0260","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1016\/j.jmb.2014.01.010","article-title":"In silico derived small molecules bind the filovirus VP35 protein and inhibit its polymerase cofactor activity","volume":"426","author":"Brown","year":"2014","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jmb.2025.169366_b0265","doi-asserted-by":"crossref","first-page":"8406","DOI":"10.1021\/bi400704d","article-title":"Development of RNA aptamers targeting Ebola virus VP35","volume":"52","author":"Binning","year":"2013","journal-title":"Biochemistry"},{"key":"10.1016\/j.jmb.2025.169366_b0270","doi-asserted-by":"crossref","first-page":"3004","DOI":"10.1128\/JVI.02459-09","article-title":"Mutations abrogating VP35 interaction with double-stranded RNA render Ebola virus avirulent in guinea pigs","volume":"84","author":"Prins","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.jmb.2025.169366_b0275","doi-asserted-by":"crossref","first-page":"11779","DOI":"10.1128\/JVI.01525-12","article-title":"Inclusion bodies are a site of Ebolavirus replication","volume":"86","author":"Hoenen","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.jmb.2025.169366_b0280","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0168-1702(95)00080-1","article-title":"Differentiation of filoviruses by electron microscopy","volume":"39","author":"Geisbert","year":"1995","journal-title":"Virus Res."},{"key":"10.1016\/j.jmb.2025.169366_b0285","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1038\/srep01206","article-title":"The spatio-temporal distribution dynamics of Ebola virus proteins and RNA in infected cells","volume":"3","author":"Nanbo","year":"2013","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jmb.2025.169366_b0290","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02100-19","article-title":"Ebola virus inclusion body formation and RNA synthesis are controlled by a novel domain of nucleoprotein interacting with VP35","volume":"94","author":"Miyake","year":"2020","journal-title":"J. Virol."},{"key":"10.1016\/j.jmb.2025.169366_b0295","doi-asserted-by":"crossref","first-page":"4159","DOI":"10.1038\/s41467-023-39821-7","article-title":"Spatial and functional arrangement of Ebola virus polymerase inside phase-separated viral factories","volume":"14","author":"Fang","year":"2023","journal-title":"Nature Commun."},{"key":"10.1016\/j.jmb.2025.169366_b0300","doi-asserted-by":"crossref","DOI":"10.1080\/22221751.2023.2223727","article-title":"Ebola virus inclusion bodies are liquid organelles whose formation is facilitated by nucleoprotein oligomerization","volume":"12","author":"Bodmer","year":"2023","journal-title":"Emerg. Microbes Infect."},{"key":"10.1016\/j.jmb.2025.169366_b0305","doi-asserted-by":"crossref","first-page":"3554","DOI":"10.1128\/JVI.02183-06","article-title":"Mapping of the VP40-binding regions of the nucleoprotein of Ebola virus","volume":"81","author":"Noda","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.jmb.2025.169366_b0310","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.virol.2013.03.013","article-title":"The L\u2013VP35 and L\u2013L interaction domains reside in the amino terminus of the Ebola virus L protein and are potential targets for antivirals","volume":"441","author":"Trunschke","year":"2013","journal-title":"Virology"},{"key":"10.1016\/j.jmb.2025.169366_b0315","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1006\/viro.1998.9328","article-title":"Interactions of Marburg virus nucleocapsid proteins","volume":"249","author":"Becker","year":"1998","journal-title":"Virology"},{"key":"10.1016\/j.jmb.2025.169366_b0320","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1006\/viro.1996.0490","article-title":"Termini of all mRNA species of Marburg virus: sequence and secondary structure","volume":"223","author":"M\u00fchlberger","year":"1996","journal-title":"Virology"},{"key":"10.1016\/j.jmb.2025.169366_b0325","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2217\/17460794.2.2.205","article-title":"Filovirus replication and transcription","volume":"2","author":"M\u00fchlberger","year":"2007","journal-title":"Future Virol."},{"key":"10.1016\/j.jmb.2025.169366_b0330","doi-asserted-by":"crossref","first-page":"33099","DOI":"10.1074\/jbc.M203775200","article-title":"Phosphorylation of VP30 impairs Ebola virus transcription","volume":"277","author":"Modrof","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jmb.2025.169366_b0335","doi-asserted-by":"crossref","first-page":"8532","DOI":"10.1128\/JVI.76.17.8532-8539.2002","article-title":"Ebola virus VP30-mediated transcription is regulated by RNA secondary structure formation","volume":"76","author":"Weik","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.jmb.2025.169366_b0340","doi-asserted-by":"crossref","first-page":"11165","DOI":"10.1074\/jbc.M113.461285","article-title":"Phosphorylation of Ebola virus VP30 influences the composition of the viral nucleocapsid complex","volume":"288","author":"Biedenkopf","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jmb.2025.169366_b0345","doi-asserted-by":"crossref","first-page":"7481","DOI":"10.1128\/JVI.00271-16","article-title":"RNA Binding of Ebola virus VP30 is essential for activating viral transcription","volume":"90","author":"Biedenkopf","year":"2016","journal-title":"J. Virol."},{"key":"10.1016\/j.jmb.2025.169366_b0350","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.virol.2004.11.018","article-title":"A reconstituted replication and transcription system for Ebola virus Reston and comparison with Ebola virus Zaire","volume":"332","author":"Boehmann","year":"2005","journal-title":"Virology"},{"key":"10.1016\/j.jmb.2025.169366_b0355","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.virusres.2008.10.017","article-title":"The Ebola virus ribonucleoprotein complex: a novel VP30-L interaction identified","volume":"140","author":"Groseth","year":"2009","journal-title":"Virus Res."},{"key":"10.1016\/j.jmb.2025.169366_b0360","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.antiviral.2011.06.003","article-title":"Minigenomes, transcription and replication competent virus-like particles and beyond: reverse genetics systems for filoviruses and other negative stranded hemorrhagic fever viruses","volume":"91","author":"Hoenen","year":"2011","journal-title":"Antiviral Res."},{"key":"10.1016\/j.jmb.2025.169366_b0365","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.cell.2024.11.024","article-title":"Nucleocapsid assembly drives Ebola viral factory maturation and dispersion","volume":"188","author":"Vallbracht","year":"2025","journal-title":"Cell"},{"key":"10.1016\/j.jmb.2025.169366_b0370","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.3390\/v13112316","article-title":"Functional importance of hydrophobic patches on the Ebola virus VP35 IFN-inhibitory domain","volume":"13","author":"Kasajima","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.jmb.2025.169366_b0375","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1010616","article-title":"Assembly and transport of filovirus nucleocapsids","volume":"18","author":"Dolnik","year":"2022","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.jmb.2025.169366_b0380","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S1097-2765(02)00588-9","article-title":"The assembly of Ebola virus nucleocapsid requires virion-associated proteins 35 and 24 and posttranslational modification of nucleoprotein","volume":"10","author":"Huang","year":"2002","journal-title":"Mol. Cell"},{"key":"10.1016\/j.jmb.2025.169366_b0385","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1292\/jvms.67.325","article-title":"Nucleocapsid-like structures of Ebola virus reconstructed using electron tomography","volume":"67","author":"Noda","year":"2005","journal-title":"J. Vet. Med. Sci."},{"key":"10.1016\/j.jmb.2025.169366_b0390","doi-asserted-by":"crossref","first-page":"e99","DOI":"10.1371\/journal.ppat.0020099","article-title":"Assembly and budding of Ebolavirus","volume":"2","author":"Noda","year":"2006","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.jmb.2025.169366_b0395","doi-asserted-by":"crossref","first-page":"3743","DOI":"10.1128\/JVI.80.8.3743-3751.2006","article-title":"Functional mapping of the nucleoprotein of Ebola virus","volume":"80","author":"Watanabe","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.jmb.2025.169366_b0400","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/nature24490","article-title":"Structure and assembly of the Ebola virus nucleocapsid","volume":"551","author":"Wan","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.jmb.2025.169366_b0405","doi-asserted-by":"crossref","first-page":"4275","DOI":"10.1073\/pnas.1120453109","article-title":"Structural dissection of Ebola virus and its assembly determinants using cryo-electron tomography","volume":"109","author":"Bharat","year":"2012","journal-title":"PNAS"},{"key":"10.1016\/j.jmb.2025.169366_b0410","doi-asserted-by":"crossref","first-page":"5587","DOI":"10.1016\/j.cell.2024.08.044","article-title":"Intracellular Ebola virus nucleocapsid assembly revealed by in situ cryo-electron tomography","volume":"187","author":"Watanabe","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.jmb.2025.169366_b0415","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1146\/annurev-immunol-032713-120231","article-title":"Interferon-stimulated genes: a complex web of host defenses","volume":"32","author":"Schneider","year":"2014","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jmb.2025.169366_b0420","doi-asserted-by":"crossref","DOI":"10.1016\/j.dci.2023.104732","article-title":"Double-stranded RNA-dependent protein kinase (PKR) in antiviral defence in fish and mammals","volume":"145","author":"Chaumont","year":"2023","journal-title":"Dev. Comp. Immunol."},{"key":"10.1016\/j.jmb.2025.169366_b0425","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1128\/MMBR.00027-06","article-title":"Impact of protein kinase PKR in cell biology: from antiviral to antiproliferative action","volume":"70","author":"Garc\u00eda","year":"2006","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"10.1016\/j.jmb.2025.169366_b0430","doi-asserted-by":"crossref","first-page":"6365","DOI":"10.1111\/febs.15691","article-title":"A tale of two proteins: PACT and PKR and their roles in inflammation","volume":"288","author":"Chukwurah","year":"2021","journal-title":"FEBS J."},{"key":"10.1016\/j.jmb.2025.169366_b0435","doi-asserted-by":"crossref","first-page":"4379","DOI":"10.1093\/emboj\/17.15.4379","article-title":"PACT, a protein activator of the interferon-induced protein kinase, PKR","volume":"17","author":"Patel","year":"1998","journal-title":"EMBO J."},{"key":"10.1016\/j.jmb.2025.169366_b0440","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.chom.2011.03.007","article-title":"The double-stranded RNA-binding protein PACT functions as a cellular activator of RIG-I to facilitate innate antiviral response","volume":"9","author":"Kok","year":"2011","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.jmb.2025.169366_b0445","doi-asserted-by":"crossref","first-page":"10005","DOI":"10.1073\/pnas.0602317103","article-title":"Molecular basis for PKR activation by PACT or dsRNA","volume":"103","author":"Li","year":"2006","journal-title":"PNAS"},{"key":"10.1016\/j.jmb.2025.169366_b0450","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1016\/j.celrep.2016.01.049","article-title":"Differential regulation of interferon responses by Ebola and Marburg virus VP35 proteins","volume":"14","author":"Edwards","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.jmb.2025.169366_b0455","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.antiviral.2012.01.005","article-title":"dsRNA binding characterization of full length recombinant wild type and mutants Zaire ebolavirus VP35","volume":"93","author":"Zinzula","year":"2012","journal-title":"Antiviral Res."},{"key":"10.1016\/j.jmb.2025.169366_b0460","doi-asserted-by":"crossref","first-page":"6430","DOI":"10.1128\/JVI.00044-06","article-title":"Reverse genetic generation of recombinant Zaire Ebola viruses containing disrupted IRF-3 inhibitory domains results in attenuated virus growth in vitro and higher levels of IRF-3 activation without inhibiting viral transcription or replication","volume":"80","author":"Hartman","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.jmb.2025.169366_b0465","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1128\/JVI.02344-07","article-title":"Inhibition of IRF-3 activation by VP35 is critical for the high level of virulence of Ebola virus","volume":"82","author":"Hartman","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.jmb.2025.169366_b0470","doi-asserted-by":"crossref","first-page":"3032","DOI":"10.1016\/j.celrep.2019.08.047","article-title":"A VP35 mutant Ebola virus lacks virulence but can elicit protective immunity to wild-type virus challenge","volume":"28","author":"Woolsey","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.jmb.2025.169366_b0475","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1128\/JVI.01160-10","article-title":"Ebolavirus proteins suppress the effects of small interfering RNA by direct interaction with the mammalian RNA interference pathway","volume":"85","author":"Fabozzi","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.jmb.2025.169366_b0480","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.chom.2013.06.010","article-title":"Mutual antagonism between the Ebola virus VP35 protein and the RIG-I activator PACT determines infection outcome","volume":"14","author":"Luthra","year":"2013","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.jmb.2025.169366_b0485","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1128\/JVI.01875-08","article-title":"Ebola virus protein VP35 impairs the function of interferon regulatory factor-activating kinases IKK\u03b5 and TBK-1","volume":"83","author":"Prins","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.jmb.2025.169366_b0490","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000493","article-title":"Ebola Zaire virus blocks type I interferon production by exploiting the host SUMO modification machinery","volume":"5","author":"Chang","year":"2009","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.jmb.2025.169366_b0495","doi-asserted-by":"crossref","first-page":"25660","DOI":"10.1074\/jbc.M804479200","article-title":"Virus infection triggers SUMOylation of IRF3 and IRF7, leading to the negative regulation of type I interferon gene expression","volume":"283","author":"Kubota","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jmb.2025.169366_b0500","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1128\/JVI.01006-06","article-title":"The VP35 protein of Ebola virus inhibits the antiviral effect mediated by double-stranded RNA-dependent protein kinase PKR","volume":"81","author":"Feng","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.jmb.2025.169366_b0505","doi-asserted-by":"crossref","first-page":"8993","DOI":"10.1128\/JVI.00523-09","article-title":"Ebola virus VP35 antagonizes PKR activity through its C-terminal interferon inhibitory domain","volume":"83","author":"Sch\u00fcmann","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.jmb.2025.169366_b0510","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.virs.2023.10.004","article-title":"Ebola virus VP35 perturbs type I interferon signaling to facilitate viral replication","volume":"38","author":"Cao","year":"2023","journal-title":"Virol. Sin."},{"issue":"Suppl 3","key":"10.1016\/j.jmb.2025.169366_b0515","doi-asserted-by":"crossref","first-page":"S127","DOI":"10.1186\/ar567","article-title":"The instructive role of dendritic cells on T-cell responses","volume":"4","author":"Sallusto","year":"2002","journal-title":"Arthritis Res."},{"key":"10.1016\/j.jmb.2025.169366_b0520","doi-asserted-by":"crossref","first-page":"12500","DOI":"10.1128\/JVI.02163-14","article-title":"Molecular basis for ebolavirus VP35 suppression of human dendritic cell maturation","volume":"88","author":"Yen","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.jmb.2025.169366_b0525","doi-asserted-by":"crossref","first-page":"5108","DOI":"10.1128\/JVI.00191-16","article-title":"Effects of filovirus interferon antagonists on responses of human monocyte-derived dendritic cells to RNA virus infection","volume":"90","author":"Yen","year":"2016","journal-title":"J. Virol."},{"key":"10.1016\/j.jmb.2025.169366_b0530","doi-asserted-by":"crossref","first-page":"7567","DOI":"10.1128\/JVI.00924-15","article-title":"Different temporal effects of Ebola virus VP35 and VP24 proteins on global gene expression in human dendritic cells","volume":"89","author":"Ilinykh","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.jmb.2025.169366_b0535","doi-asserted-by":"crossref","first-page":"7471","DOI":"10.1128\/JVI.03316-12","article-title":"The lack of maturation of Ebola virus-infected dendritic cells results from the cooperative effect of at least two viral domains","volume":"87","author":"Lubaki","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.jmb.2025.169366_b0540","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006031","article-title":"The Ebola interferon inhibiting domains attenuate and dysregulate cell-mediated immune responses","volume":"12","author":"Lubaki","year":"2016","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.jmb.2025.169366_b0545","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nrg2968","article-title":"Current prospects for RNA interference-based therapies","volume":"12","author":"Davidson","year":"2011","journal-title":"Nature Rev. Genet."},{"key":"10.1016\/j.jmb.2025.169366_b0550","doi-asserted-by":"crossref","first-page":"e86","DOI":"10.1371\/journal.ppat.0030086","article-title":"The Ebola virus VP35 protein is a suppressor of RNA silencing","volume":"3","author":"Haasnoot","year":"2007","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.jmb.2025.169366_b0555","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1128\/JVI.05741-11","article-title":"Characterization of the RNA silencing suppression activity of the Ebola virus VP35 protein in plants and mammalian cells","volume":"86","author":"Zhu","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.jmb.2025.169366_b0560","doi-asserted-by":"crossref","first-page":"5837","DOI":"10.1093\/nar\/gkz340","article-title":"Ebola virus VP35 has novel NTPase and helicase-like activities","volume":"47","author":"Shu","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jmb.2025.169366_b0565","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1016\/j.cell.2018.08.044","article-title":"Protein interaction mapping identifies RBBP6 as a negative regulator of Ebola virus replication","volume":"175","author":"Batra","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.jmb.2025.169366_b0570","article-title":"A protein-proximity screen reveals Ebola virus co-opts the mRNA decapping complex through the scaffold protein EDC4","author":"Davey","year":"2024","journal-title":"Res. Square"},{"key":"10.1016\/j.jmb.2025.169366_b0575","doi-asserted-by":"crossref","first-page":"6952","DOI":"10.1128\/JVI.00480-09","article-title":"Ebolavirus VP35 interacts with the cytoplasmic dynein light chain 8","volume":"83","author":"Kubota","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.jmb.2025.169366_b0580","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/nature11289","article-title":"Viral immune modulators perturb the human molecular network by common and unique strategies","volume":"487","author":"Pichlmair","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.jmb.2025.169366_b0585","doi-asserted-by":"crossref","first-page":"S911","DOI":"10.1093\/infdis\/jir343","article-title":"DRBP76 associates with Ebola virus VP35 and suppresses viral polymerase function","volume":"204","author":"Shabman","year":"2011","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jmb.2025.169366_b0590","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1038\/s41467-022-29948-4","article-title":"Ebola virus VP35 hijacks the PKA-CREB1 pathway for replication and pathogenesis by AKIP1 association","volume":"13","author":"Zhu","year":"2022","journal-title":"Nature Commun."},{"key":"10.1016\/j.jmb.2025.169366_b0595","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1146\/annurev-biochem-060310-170328","article-title":"The ubiquitin code","volume":"81","author":"Komander","year":"2012","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.jmb.2025.169366_b0600","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/v13030369","article-title":"The role of the host ubiquitin system in promoting replication of emergent viruses","volume":"13","author":"Valerdi","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.jmb.2025.169366_b0605","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/JVI.00833-17","article-title":"The host E3-ubiquitin ligase TRIM6 ubiquitinates the Ebola virus VP35 protein and promotes virus replication","volume":"91","author":"Bharaj","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/j.jmb.2025.169366_b0610","first-page":"1","article-title":"Ubiquitination of Ebola virus VP35 at lysine 309 regulates viral transcription and assembly","author":"Van Tol","year":"2022","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.jmb.2025.169366_b0615","doi-asserted-by":"crossref","first-page":"22335","DOI":"10.1074\/jbc.M501631200","article-title":"Mind bomb-2 is an E3 ligase for Notch ligand","volume":"280","author":"Koo","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jmb.2025.169366_b0620","doi-asserted-by":"crossref","first-page":"12765","DOI":"10.1128\/JVI.02037-14","article-title":"Lysine 63-linked TANK-binding kinase 1 ubiquitination by mindbomb E3 ubiquitin protein ligase 2 is mediated by the mitochondrial antiviral signaling protein","volume":"88","author":"Ye","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.jmb.2025.169366_b0625","doi-asserted-by":"crossref","first-page":"14135","DOI":"10.1074\/jbc.RA119.010119","article-title":"The E3 ubiquitin ligase MIB2 enhances inflammation by degrading the deubiquitinating enzyme CYLD","volume":"294","author":"Uematsu","year":"2019","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.jmb.2025.169366_b0630","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.immuni.2011.06.014","article-title":"Mapping a dynamic innate immunity protein interaction network regulating type I interferon production","volume":"35","author":"Li","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.jmb.2025.169366_b0635","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1038\/embor.2008.136","article-title":"The tumour suppressor CYLD is a negative regulator of RIG-I-mediated antiviral response","volume":"9","author":"Friedman","year":"2008","journal-title":"EMBO Rep."},{"key":"10.1016\/j.jmb.2025.169366_b0640","article-title":"Ebola virus VP35 NNLNS motif modulates viral RNA synthesis and MIB2-mediated signaling","author":"Uwase","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.jmb.2025.169366_b0645","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3002544","article-title":"Ebola virus VP35 interacts non-covalently with ubiquitin chains to promote viral replication","volume":"22","author":"Rodr\u00edguez-Salazar","year":"2024","journal-title":"PLoS Biol."},{"key":"10.1016\/j.jmb.2025.169366_b0650","article-title":"Global phosphoproteomic analysis of Ebola virions reveals a novel role for VP35 phosphorylation \u2013 dependent regulation of genome transcription","volume":"35","author":"Ivanov","year":"2019","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.jmb.2025.169366_b0655","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.1111\/j.1742-4658.2011.08254.x","article-title":"DYNLL\/LC8: a light chain subunit of the dynein motor complex and beyond","volume":"278","author":"Rapali","year":"2011","journal-title":"FEBS J."},{"key":"10.1016\/j.jmb.2025.169366_b0660","doi-asserted-by":"crossref","first-page":"5148","DOI":"10.1128\/JVI.03652-14","article-title":"Ebola virus VP35 interaction with dynein LC8 regulates viral RNA synthesis","volume":"89","author":"Luthra","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.jmb.2025.169366_b0665","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/35085068","article-title":"Transcriptional regulation by the phosphorylation-dependent factor CREB","volume":"2","author":"Mayr","year":"2001","journal-title":"Nature Rev. Mol. Cell Biol."},{"key":"10.1016\/j.jmb.2025.169366_b0670","doi-asserted-by":"crossref","first-page":"20432","DOI":"10.1074\/jbc.274.29.20432","article-title":"DRBP76, a double-stranded RNA-binding nuclear protein, is phosphorylated by the interferon-induced protein kinase, PKR","volume":"274","author":"Patel","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jmb.2025.169366_b0675","doi-asserted-by":"crossref","first-page":"7263","DOI":"10.1093\/nar\/gkr278","article-title":"EBP1 and DRBP76\/NF90 binding proteins are included in the major histocompatibility complex class II RNA operon","volume":"39","author":"Corso","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jmb.2025.169366_b0680","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01771-18","article-title":"Staufen1 interacts with multiple components of the Ebola virus ribonucleoprotein and enhances viral RNA synthesis","volume":"9","author":"Fang","year":"2018","journal-title":"MBio"},{"key":"10.1016\/j.jmb.2025.169366_b0685","doi-asserted-by":"crossref","first-page":"7145","DOI":"10.1007\/s00018-021-03965-w","article-title":"The multifunctional RNA-binding protein Staufen1: an emerging regulator of oncogenesis through its various roles in key cellular events","volume":"78","author":"Almasi","year":"2021","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.jmb.2025.169366_b0690","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1093\/femsre\/fuw010","article-title":"Neglected filoviruses","volume":"40","author":"Burk","year":"2016","journal-title":"FEMS Microbiol. Rev."},{"key":"10.1016\/j.jmb.2025.169366_b0695","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1080\/21505594.2021.1898169","article-title":"Pathogenicity and virulence of Ebolaviruses with species- and variant-specificity","volume":"12","author":"Yamaoka","year":"2021","journal-title":"Virulence"},{"key":"10.1016\/j.jmb.2025.169366_b0700","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.jmb.2010.04.022","article-title":"Structural and functional characterization of Reston Ebola virus VP35 interferon inhibitory domain","volume":"399","author":"Leung","year":"2010","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jmb.2025.169366_b0705","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002916","article-title":"Marburg virus VP35 can both fully coat the backbone and cap the ends of dsRNA for interferon antagonism","volume":"8","author":"Bale","year":"2012","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.jmb.2025.169366_b0710","doi-asserted-by":"crossref","first-page":"20661","DOI":"10.1073\/pnas.1213559109","article-title":"Structural basis for Marburg virus VP35-mediated immune evasion mechanisms","volume":"109","author":"Ramanan","year":"2012","journal-title":"PNAS"},{"key":"10.1016\/j.jmb.2025.169366_b0715","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.celrep.2018.06.045","article-title":"Conservation of structure and immune antagonist functions of filoviral VP35 homologs present in microbat genomes","volume":"24","author":"Edwards","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.jmb.2025.169366_b0720","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01085-16","article-title":"Crystal structure of the Marburg virus VP35 oligomerization domain","volume":"91","author":"Bruhn","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/j.jmb.2025.169366_b0725","doi-asserted-by":"crossref","first-page":"14876","DOI":"10.1128\/JVI.79.23.14876-14886.2005","article-title":"Homo-oligomerization of Marburgvirus VP35 is essential for its function in replication and transcription","volume":"79","author":"M\u00f6ller","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.jmb.2025.169366_b0730","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.virol.2014.12.002","article-title":"Recombinant Marburg viruses containing mutations in the IID region of VP35 prevent inhibition of host immune responses","volume":"476","author":"Albari\u00f1o","year":"2015","journal-title":"Virology"},{"key":"10.1016\/j.jmb.2025.169366_b0735","first-page":"S403","article-title":"Marburg virus viral protein 35 inhibits protein kinase R activation in a cell type-specific manner","volume":"218","author":"Hume","year":"2018","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jmb.2025.169366_b0740","doi-asserted-by":"crossref","first-page":"660","DOI":"10.3390\/biom14060660","article-title":"Identification of prospective Ebola virus VP35 and VP40 protein inhibitors from myxobacterial natural products","volume":"14","author":"Hayat","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.jmb.2025.169366_b0745","doi-asserted-by":"crossref","first-page":"5388","DOI":"10.1016\/j.bmc.2016.08.065","article-title":"In silico and in vitro methods to identify ebola virus VP35-dsRNA inhibitors","volume":"24","author":"Glanzer","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.jmb.2025.169366_b0750","doi-asserted-by":"crossref","first-page":"14791","DOI":"10.3390\/ijms241914791","article-title":"Novel antiviral molecules against Ebola virus infection","volume":"24","author":"Collados Rodr\u00edguez","year":"2023","journal-title":"IJMS"},{"key":"10.1016\/j.jmb.2025.169366_b0755","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s12896-019-0554-2","article-title":"Intracellular human antibody fragments recognizing the VP35 protein of Zaire Ebola filovirus inhibit the protein activity","volume":"19","author":"Flego","year":"2019","journal-title":"BMC Biotechnol."},{"key":"10.1016\/j.jmb.2025.169366_b0760","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1006\/viro.2001.1012","article-title":"Vaccine potential of Ebola virus VP24, VP30, VP35, and VP40 proteins","volume":"286","author":"Wilson","year":"2001","journal-title":"Virology"},{"key":"10.1016\/j.jmb.2025.169366_b0765","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/msb.2011.75","article-title":"Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega","volume":"7","author":"Sievers","year":"2011","journal-title":"Mol. Syst. Biol."},{"key":"10.1016\/j.jmb.2025.169366_b0770","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1093\/bioinformatics\/btp033","article-title":"Jalview Version 2\u2013a multiple sequence alignment editor and analysis workbench","volume":"25","author":"Waterhouse","year":"2009","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jmb.2025.169366_b0775","doi-asserted-by":"crossref","first-page":"W320","DOI":"10.1093\/nar\/gku316","article-title":"Deciphering key features in protein structures with the new ENDscript server","volume":"42","author":"Robert","year":"2014","journal-title":"Nucleic Acids Res."}],"container-title":["Journal of Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022283625004322?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022283625004322?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T08:24:42Z","timestamp":1774945482000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022283625004322"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":155,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S0022283625004322"],"URL":"https:\/\/doi.org\/10.1016\/j.jmb.2025.169366","relation":{},"ISSN":["0022-2836"],"issn-type":[{"value":"0022-2836","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"25\u00a0Years of Ebola Virus VP35 Research","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmb.2025.169366","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"169366"}}